-
IDH1-R132H Autopalmitoylation in Cancer
2026-09-13
The reference study identifies C269 autopalmitoylation as a mutation-associated regulatory switch that enhances IDH1-R132H substrate and cofactor binding, dimerization, and production of the oncometabolite (R)-2-hydroxyglutarate. Its chemoproteomic, biochemical, and cellular evidence connects fatty-acid availability with mutant IDH1 activity and suggests that the modification site lies within a therapeutically relevant hydrophobic pocket.
-
Disulfiram Workflows for Proteasome and Cancer Research
2026-09-12
Disulfiram supports two complementary research directions: copper-associated proteasome inhibition in tumor models and ALDH2-linked synthetic lethality in APC-deficient colorectal cancer. This workflow guide connects biochemical assays, cell-based apoptosis measurements, genotype-aware experiments, and practical formulation controls.
-
HATU for Peptide Synthesis and Amide Bond Formation
2026-09-12
HATU accelerates carboxylic acid activation for demanding amide and ester formation, making it useful in peptide synthesis, medicinal chemistry, and inhibitor-library workflows. This guide connects practical coupling conditions with the stereochemical and assay-design lessons from selective IRAP inhibitor discovery.
-
Lopinavir (ABT-378): HIV Protease Research Guide
2026-09-11
Lopinavir, also known as ABT-378, is a potent HIV protease inhibitor with picomolar biochemical activity against wild-type and selected mutant proteases. This guide separates HIV assay benchmarks from exploratory coronavirus cell-culture findings and provides evidence-aware workflow guidance.
-
Neuromedin S (rat): Practical GPCR Assay Guide
2026-09-11
Neuromedin S (rat), SKU B5466, provides a defined peptide agonist input for controlled neuromedin U receptor signaling and GPCR/G protein signaling workflows. It is intended for research assay development and pathway studies, not for diagnostic, therapeutic, or medical use, and its assay potency should be established experimentally because no directly matched paper evidence is supplied.
-
GTP Solution for p21 mRNA Workflows
2026-09-10
A practical guide to using a defined GTP Solution in IVT mRNA, RNA amplification, and localized therapeutic research. It connects nucleotide handling and assay controls with the p21 mRNA–LNP bladder cancer workflow while separating reagent performance from biological outcomes.
-
TSSK2 Inhibitors: Potent Pyrimidine Scaffolds
2026-09-10
Hawkinson and colleagues used a mobility-shift high-throughput screen to identify pyrrolopyrimidine and pyrimidine inhibitors of the reproductive kinase TSSK2, including the first sub-100 nM inhibitors reported for a TSSK isoform beyond staurosporine. The study provides a useful medicinal-chemistry framework for dual TSSK1/2 inhibition while also showing why biochemical potency must be separated from cellular, reproductive, and cross-disease claims.
-
Trilaurin Workflows for Oral Lipid Delivery
2026-09-09
Trilaurin, also known as Glycerol Tridodecanoate, combines a defined C12 triacylglycerol structure with practical value in solid lipid particles, enzyme-enabled synthesis, and advanced oral delivery. This workflow-focused guide translates digestion and proteolysis data into assay design, formulation choices, and troubleshooting decisions.
-
Kanamycin Sulfate: Mechanism and Research Use
2026-09-09
Kanamycin Sulfate is a water-soluble antibiotic and aminoglycoside research reagent that inhibits bacterial protein synthesis through 30S ribosomal-subunit binding. Its documented solubility, storage requirements, and resistance-selection applications support reproducible microbiology workflows, while circRNA purification evidence defines a separate RNA-processing context.
-
Nuclear mTORC1 Control Revealed by TerminaTOR
2026-09-08
The reference study introduces TerminaTOR, a genetically encodable inhibitor that selectively perturbs mTORC1 at defined subcellular locations. Its results show that lysosomal and nuclear mTORC1 support distinct outputs, with nuclear mTORC1 regulating transcription of CCAAT motif-containing genes rather than simply duplicating canonical lysosomal signaling.
-
Radioiodinated Balsalazide for UC Imaging in Mice
2026-09-08
The reference study developed and evaluated radioiodinated balsalazide as a colon-directed tracer for ulcerative colitis in mice, combining optimized labeling chemistry with stability and biodistribution testing. Its high uptake in ulcerated colon supports further investigation of balsalazide-based molecular imaging, while the animal-only design limits direct clinical translation.
-
Leucovorin Calcium in Gastric Cancer Assays
2026-09-07
Leucovorin Calcium can function as more than a methotrexate-rescue reagent: in patient-derived gastric cancer assembloids, it helps separate epithelial folate dependence from stromal modulation. This article translates assembloid evidence into practical assay design and interpretation.
-
MG-132 and Chondrosarcoma: From Proteostasis to Translation
2026-09-05
MG-132, also known as Z-LLL-al, offers a practical chemical probe for testing whether proteostasis stress can expose the NAD+ and SIRT1-HIF-2α vulnerabilities identified in chondrosarcoma. This thought-leadership guide connects mechanistic biology with experimental design, translational positioning, and responsible interpretation.
-
HyperScribe All in One mRNA Synthesis Kit Plus 1
2026-09-05
The HyperScribe All in One mRNA Synthesis Kit Plus 1 connects transcript architecture with assay interpretation, combining ARCA capping, modified nucleotides, DNase treatment, and poly(A) tailing. This guide explains how those design choices inform translation studies, RNA vaccine development, and immune-response analysis.
-
S1P/S1PR3 Drives Neuronal Apoptosis After ICH
2026-09-04
The reference study identifies an S1P–S1PR3 axis that connects acute intracerebral hemorrhage with CCL2 and TNF-α induction, PI3K/AKT-associated signaling, and caspase-3 activation in neurons. Mouse and HT22-cell experiments suggest that pharmacological S1PR3 blockade reduces apoptosis and improves injury-associated outcomes, while also highlighting the receptor-context dependence of S1P biology.